ABSTRACT Recent evidence suggests that certain actions of insulin may be mediated by the selective generation of chemically undefined intracellular substances. Incubation of rat liver particulate fraction with low concentrations of insulin enhances the release into the supernatant of a substance that stimulates mitochondrial pyruvate dehydrogenase. Higher concentrations of insulin release less stimulating activity. It is possible to resolve activities that stimulate and inhibit pyruvate dehydrogenase by differential ethanol extraction of the supernatant solutions. The elaboration of both factors is dependent upon the presence of insulin in a dose-dependent manner. Moreover, fractions that contain the pyruvate dehydrogenase-inhibiting activity also inhibit adipocyte basal and hormonally stimulated adenylate cyclase. The production of this adenylate cyclase inhibitory activity is also stimulated by insulin. Cyclase inhibition is virtually abolished when the nonhydrolyzable ATP analog, 5'-adenylyl imidodiphosphate, is included in the assay. These results indicate that the bimodal effects of insulin on certain functions may be ascribed to the generation of at least two distinct chemical substances that show opposing activities, which may operate by regulating phosphorylation reactions.
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Our understanding of the molecular events involved in the physiological actions of insulin remains incomplete. The binding of insulin to its receptor on the target cell surface, and the modulation by insulin of a number of intracellular enzymes, have been studied extensively (1, 2) . Several ofthese enzymes, such as glycogen synthetase (3) , pyruvate dehydrogenase complex (PDHase; EC 1.2.2.2 and 1.2.4.1) (4), and pyruvate kinase (5) , appear to be regulated by phosphorylation-dephosphorylation reactions. Similar processes have been postulated for Ca2+, Mg2+-ATPase (6) , cyclic AMP phosphodiesterase (7) , and adenylate cyclase (EC 4.6.1.1) (8, 9) . It recently has been shown that exposure ofplasma membranes from rat adipocytes (10, 11) , skeletal muscle (3, 12) , and liver (13) to insulin results in the release ofone or more low-molecular-weight substances, which in turn can affect certain insulin-sensitive enzymes in broken cell preparations. It has been proposed that these chemical mediators act on PDHase (14) and glycogen synthetase (3) by controlling their state of phosphorylation.
Because insulin-sensitive target tissues are known to be under the regulatory influence of cyclic nucleotides, the effects of insulin on the levels of cyclic AMP have been examined extensively. Early reports (15, 16) demonstrated that insulin inhibited the catecholamine-or glucagon-stimulated rise in cellular cyclic AMP. It was later shown in intact fat and liver cells that insulin could activate the high-affinity form of cyclic AMP phosphodiesterase (17) . Furthermore, other evidence indicated that insulin could directly inhibit the adenylate cyclase activity of isolated membranes from adipocytes (18) , liver cells (19, 20) , and fibroblasts (21) . Although the changes in cyclic nucleotide levels probably cannot account for all of the numerous actions of insulin (22) Generation of Insulin Mediators. These were prepared by a modification of the method as described (13) . Rat livers were washed in 10 mM potassium phosphate buffer (pH 7.4) and homogenized by using a Teflon/glass homogenizer. The homogenate was filtered through four layers of cheesecloth and centrifuged at 30,000 x g for 25 min. The pellet was rehomogenized and sedimented at 1,100 x g for 10 min. The supernatant was centrifuged again at 30,000 X g for 25 min. The pellet was resuspended in the same buffer (2-4 mg of protein per ml, referred to as "particulate fraction") and incubated with insulin for designated times at 37°C. An equal volume of0.2 M acetate buffer, pH 3.75/0.1 mM dithiothreitoV0.1 mM EDTA was then added. After cent'rifugation at 30,000 x g for 15 min, the aspirated supernatant was treated with activated charcoal for 10 min at 4°C. Charcoal was removed by centrifugation at 12,000 X g for 10 min, and the supernatant was lyophilized. The stimulatory and inhibitory factors were separated by extracting the lyophilized powder twice with 100% ethanol. The powder was suspended in ethanol, sonicated for 5 min, and centrifuged at 500 X g for 20 min. The ethanol supernatants from two such procedures were pooled and centrifuged again before drying under N2 and suspending in 1 mM formic acid. The nonextractable residue, which contained the stimulatory activity, was suspended in 1 mM formic acid and centrifuged at 10,000 X g for 10 min. Neither the stimulatory or inhibitory activities were destroyed when, the extracted supernatants were boiled for 5 min.
Abbreviations: PDHase, pyruvate dehydrogenase; EC50, half-maximal effective concentration; p[NH]ppA, 5'-adenylyl imidodiphosphate.
The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. 7.2) .and centrifuged at 500 X g for 10 min. The supernatant was centrifuged at 9,000 x g for 10min. The pellet was homogenized in an equal volume of buffer A, and the two centrifugation steps were repeated. The fluffy layer above the pellet was discarded, and the pellet was homogenized in buffer A and centrifuged at 9,000 X g for 10 min.
The pellet consisted of whole mitochondria whose PDHase activity was sensitive to the extracted mediators. To enhance enzyme sensitivity, the outer mitochondrial membranes were detached by swelling in 10 vol of 20 (Fig. 1) . As described earlier for adipocyte mitochondria, the crude .extracts produced a biphasic dose-response curve intliver mitoplasts (Fig. 1A) . However, the ethanol-extracted residue caused only a dose-dependent stimulatory effect on the PDHase activity of mitoplasts deactivated by pretreatment with 0.2 mM ATP; no inhibitory phase was detected (Fig.1B) . In contrast, the ethanol-extractable material caused a dose-dependent decrease in PDHase activity (Fig.lC) . This inhibition was most pronounced when ATP was present in the assay medium. Thus, the crude material released from liver membranes contains both inhibitory and Incubation of rat liver particulate fractions with increasing concentrations of insulin resulted in a dose-dependent generation ofboth the stimulatory and inhibitory factors (Fig. 2) . The concentration of insulin required for the half-maximal production of stimulatory activity (EC50) was about 0.03 nM, whereas that for the inhibitory activity was about 0.18 nM. The apparent biphasic nature of the insulin dose-response curves of crude extracts may be due in part to this differential sensitivity to insulin (13) .
Inhibition of Adenylate Cyclase Activity. The material not extractable by ethanol had no effect on the adenylate cyclase activity of purified adipocyte membranes (data not shown); it is difficult to exclude the possibility that a stimulatory activity in this fraction was masked by other inhibitory agents. On the other hand, the ethanol-extracted material markedly inhibited the enzyme (Table 1) . The basal and isoproterenol-stimulated activities are decreased in the presence of this extract by 60-70%. However, fluoride-stimulated activity, was inhibited by only 30%. As described (26) , GTP inhibited adipocyte adenylate cyclase with a maximal effect at 1-2 ,M. In the presence of0.5 AM or 10 ,M GTP, the ethanol-extractable material further inhibited the activity (Table 1 ). In the presence of isoproterenol, the GTP dose-response curve for adipocyte cyclase is biphasic (27) . The ethanol extract can depress the activity of adenylate cyclase in the presence of either stimulatory (0.5 ,uM) or inhibitory (10 ,M) concentrations of GTP (Table 1) .
Effect of Insulin on the Generation of an Inhibitor of Adenylate Cyclase. Insulin produced a dose-dependent increase in the ethanol-extractable inhibitory activity released from liver particulate fractions (Fig. 3) . Half-maximal stimulation of the production of adenylate cyclase inhibitory activity occurred with 0.4 nM insulin. The material extracted from liver particulate material in the absence of insulin produced some (< 15%) inhibition of cyclase activity, but no activity was detected in parallel extractions with equal volumes of buffer in the absence of liver particulates. Under the conditions used, insulin did not inhibit cyclase activity when added directly to the assay of the adipocyte membranes (which had been prepared in the presence of 1 mM dithiothreitol).
ATP Requirement for the Action of the Adenylate Cyclase Inhibitory Activity. It has been suggested that adenylate cyclase may be inhibited by phosphorylation of the enzyme (8, 9) . To determine whether phosphorylation might be involved in the (1982) inhibitory activity studied here, the effects ofATP and the nonhydrolyzable substrate analog 5'-adenylyl imidodiphosphate (p[NH]ppA) were studied (Fig. 4) . The ethanol-extracted material produced a dose-dependent decrease in adenylate cyclase activity in the presence of ATP. However, virtually no inhibition occurred when p[NH]ppA was substituted for ATP.
Studies using various substrate concentrations demonstrated that adenylate cyclase activity reaches its maximal level with 0.2 mM ATP, with an apparent Km for ATP ofabout 5 X 10-5 (Fig.   5 ). The ethanol-extractable inhibitory activity decreased the Vm. for the enzyme, with no apparent effect on the Km.
Further Characterization of Insulin Mediators. We have shown (13) that the crude extract from liver membranes that modulates PDHase can be chromatographed on an HPLC molecular sieve column (I-60, Waters Associates). Comparison of its elution profile with parallel chromatography on Sephadex G-25 suggested that the molecular weight of the mediator was -1,000-2,000. The two resolved modulators of PDHase described in the present studies were coeluted on an HPLC 1-60 column with the same retention time as that previously observed for the crude extract. Moreover, the adenylate cyclase inhibitor was eluted similarly, suggesting that the inhibitor(s) and stimulator may be of similar molecular weight.
DISCUSSION
Recent attempts to explain the biochemical actions of insulin on cellular metabolic processes have suggested the existence of a chemical mediator that is released from the plasma membranes of target cells upon incubation with the hormone (3, 10-14, [28] [29] [30] . The known effects of insulin on glycogen synthetase from skeletal muscle (3) and on PDHase from adipocytes (10) (11) (12) (13) (14) and liver (13) substance. In nearly all cases, the effects of insulin on the generation of this substance appear to be biphasic with respect to the concentration of hormone (10, 11, 13, 14, 30) . Low concentrations of insulin elaborate a stimulator of PDHase, whereas the degree of stimulation is decreased significantly at higher concentrations. Insulin at 7-10 nM produces no detectable PDHase "stimulator" from adipocyte membranes, although there is a 2-to 3-fold increase in this activity at low concentrations (30) . It has been suggested (13, (28) (29) (30) that these paradoxical effects of insulin might be attributable to the release of two antagonistic substances. Cheng et aL (29) described the separation of stimulatory and inhibitory activities of glycogen synthetase phosphatase by high-voltage paper electrophoresis. Seals and Czech (30) speculated that both an inhibitor and an activator of PDHase were released from adipocyte plasma membranes and that these could be distinguished by the kinetics of their generation by insulin.
Data presented here confirm these suggestions by achieving a separation of these two antagonistic activities. Extraction of the lyophilized supernatant of liver membrane incubations with 100% ethanol removes the inhibitory from the stimulatory activity, resulting in monophasic dose-response curves (Fig. 1) . The production of both components is regulated by physiological concentrations of insulin, although production of the stimulator appears to be more sensitive to the hormone after 5 min of incubation. Although the relationship between the two factors is not yet clear, these results imply the existence of an intrinsic homeostatic mechanism for the regulation ofPDHase by insulin and might perhaps be related to the paradoxical effects of insulin on lipolysis in adipocytes (31, 32) .
Insulin can inhibit the rise in cyclic AMP levels produced by lipolytic hormones in fat cells (15) . Although this perhaps can be explained in part by activation (in vivo) of the high-affinity form of cyclic AMP phosphodiesterase (17) , insulin can still reduce the catecholamine-induced rise in cyclic AMP in the presence of phosphodiesterase inhibitors (16) . Also, insulin added 3"5516 Biochemistry: Saltiel et aL Proc. Natl. Acad. Sci. USA 79 (1982) 3517 directly to adipocyte (18) or liver (19, 20) (unpublished) . Interestingly, the inhibition of adipocyte adenylate cyclase occurs at doses of extract equivalent to those which inhibit PDHase. The adenylate cyclase inhibitor and the PDHase inhibitor also have been coextracted from isolated fat cell plasma membranes and intact rat hepatocytes upon treatment with insulin (unpublished data). The quantity of adenylate cyclase inhibitory activity generated from adipocyte and liver membranes occurs with concentrations of insulin approximately equal to those that produce the PDHase inhibitor. These findings, together with the apparent coelution of the PDHase and adenylate cyclase inhibitors on HPLC, suggest that perhaps a single insulin-dependent substance may be responsible for both of these activities.
It has been proposed that adenylate cyclase may be regulated by phosphorylation-dephosphorylation reactions (8, 9) . Notably, the action of the insulin-stimulated inhibitor of adenylate cyclase does not proceed if p[NH]ppA, a nonhydrolyzable analog ofATP, is used in the adenylate cyclase assay (Fig. 4) . Thus, the inhibitor may well exert its action through the control of a protein phosphorylation step, in analogy to that postulated for the PDHase regulator (14) .
Although the chemical nature of these two antagonistic substances remains elusive, some things are known regarding their production and properties. The material that stimulates PDHase is not absorbed to charcoal, is insensitive to boiling, and has a molecular weight of 1,000-3,000 (3, (10) (11) (12) (13) (14) . Seals and Czech (30) have further suggested that it may be peptidic in nature and that it exhibits a net negative charge at neutral pH. Although the relationship ofthis substance to the PDHase inhibitor is not known, it has a similar molecular weight, is not absorbed to charcoal, and is also boiling-insensitive. Because this substance can be extracted differentially with ethanol, it is probably somewhat more hydrophobic. Moreover, the inhibitor of PDHase appears to copurify with the inhibitor of adenylate cyclase, and it exhibits very similar chemical properties and responsiveness to insulin. Endogenous adenylate cyclase inhibitors have been identified earlier (33) (34) (35) . Whether the substance described here is related to other, previously described inhibitors will become evident with further purification and characterization.
